This week, the FDA granted priority review status to J&J’s JNJ application seeking approval of key pipeline candidate ...

Bagsværd, Denmark Friday, January 10, 2025, 11:00 Hrs [IST] ...

Shares of Novo Nordisk NVO gained 2.8% on Wednesday likely because the analysts at UBS upgraded the company’s rating from ...

Developers are now working on new versions and improving the results of artificial intelligence.

Doctors have an overwhelming amount of individual patient data and medical research at their disposal to make diagnoses and ...

Innovaccer has raised a $275M Series F from investors including B Capital Group, Banner Health, Danaher Ventures, Generation ...

Hippocratic AI, a startup building AI solutions that can handle non-diagnostic patient-facing tasks, secured a massive $141 ...

Healthcare AI company Innovaccer closed a $275 million Series F funding round, bringing its fundraising total to date to $675 ...

Preparing cancer patients for difficult decisions is an oncologist's job. They don't always remember to do it, however.

Johnson & Johnson received Priority Review of nipocalimab in generalized myasthenia gravis. GSK’s B7-H3-targeted ...

In November 2023, the estates of two now-deceased policyholders sued the US health insurer, United Healthcare, for deploying ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...